Ansgar Brock

Title: Ansgar Brock: Innovator in Antibody Technology and Liquid Deposition Systems

Introduction

Ansgar Brock is a notable inventor based in San Diego, CA. He has made significant contributions to the fields of biotechnology and liquid deposition technology. With a total of 4 patents to his name, Brock's work has the potential to impact various medical and scientific applications.

Latest Patents

Brock's latest patents include innovative technologies that address critical challenges in healthcare and laboratory processes. One of his key inventions is the "Antibody molecules to CD73 and uses thereof." This patent discloses antibody molecules that bind to CD73, which can be utilized for the treatment, prevention, and diagnosis of cancer. Another significant patent is the "Sample deposition method and system." This invention describes a method and system for rapidly and accurately depositing liquid droplets onto a sample plate. The technology involves forming an electric field to pull droplets to target locations, enhancing the efficiency of sample analysis.

Career Highlights

Throughout his career, Ansgar Brock has worked with reputable organizations, including Irm LLC and Leland Stanford Junior University. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in his fields of expertise.

Collaborations

Brock has collaborated with notable individuals in his field, including Christopher M. Shaw and Robert Charles Downs. These partnerships have likely fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Ansgar Brock's contributions to antibody technology and liquid deposition systems highlight his role as an influential inventor. His patents not only showcase his innovative spirit but also hold promise for future advancements in medical and scientific applications.